Chemoinformaics analysis of METHOXYEGLANDINE N-OXIDE
| Molecular Weight | 398.459 | nRot | 3 |
| Heavy Atom Molecular Weight | 372.251 | nRig | 26 |
| Exact Molecular Weight | 398.184 | nRing | 7 |
| Solubility: LogS | -2.258 | nHRing | 5 |
| Solubility: LogP | 2.617 | No. of Aliphatic Rings | 5 |
| Acid Count | 0 | No. of Aromatic Rings | 2 |
| Base Count | 1 | No. of Aliphatic Carbocycles Rings | 1 |
| Atoms Count | 55 | No. of Aliphatic Hetero Cycles | 4 |
| No. of Heavy Atom | 29 | No. of Aromatic Carbocycles | 1 |
| nHetero | 7 | No. of Aromatic Hetero Cycles | 1 |
| nBridge Head | 5 | No. Saturated Carbocycles | 1 |
| No. of Hydrogen atom | 26 | No. of Saturated Hetero Cycles | 3 |
| No. of Carbon atom | 22 | No. of Saturated Rings | 4 |
| No. of Nitrogen atom | 2 | No. of Arom Atom | 9 |
| No. of Oxygen atom | 5 | No. of Arom Bond | 10 |
| nHA | 5 | APOL | 60.2866 |
| nHD | 1 | BPOL | 34.7374 |
| QED | 0.488 |
| Synth | 6.221 |
| Natural Product Likeliness | 1.122 |
| NR-PPAR-gamma | 0.007 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.001 |
| Pgp-sub | 0.999 |
| HIA | 0.935 |
| CACO-2 | -5.596 |
| MDCK | 0.0000141 |
| BBB | 0.322 |
| PPB | 0.894331 |
| VDSS | 1.057 |
| FU | 0.0783389 |
| CYP1A2-inh | 0.038 |
| CYP1A2-sub | 0.886 |
| CYP2c19-inh | 0.597 |
| CYP2c19-sub | 0.865 |
| CYP2c9-inh | 0.215 |
| CYP2c9-sub | 0.839 |
| CYP2d6-inh | 0.013 |
| CYP2d6-sub | 0.832 |
| CYP3a4-inh | 0.9 |
| CYP3a4-sub | 0.918 |
| CL | 8.855 |
| T12 | 0.861 |
| hERG | 0.008 |
| Ames | 0.053 |
| ROA | 0.98 |
| SkinSen | 0.043 |
| Carcinogencity | 0.948 |
| EI | 0.075 |
| Respiratory | 0.832 |
| NR-Aromatase | 0.002 |
| Antiviral | Yes |
| Prediction | 0.745274 |